LASA SUPERGENERICS LTD
LASA · General/Diversified · NSE
₹8
Current Market Price
Fair Value (DCF)
₹5
Discount to FV
-29.5%
Updated just now
YieldIQ Score
43/100
Piotroski F-Score
6/9
Economic Moat
None
Confidence
46%
ROE
-17.6%
Debt/Equity
0.03
WACC
11.1%
Market Cap
₹38.43 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
-5.1%
Return on capital employed
EV / EBITDA
8.7×
Enterprise multiple
Debt / EBITDA
0.4×
Leverage vs earnings
Interest Coverage
-6.2×
EBIT covers interest
Current Ratio
1.90×
Short-term liquidity
Asset Turnover
1.40×
Revenue per ₹ of assets
Revenue CAGR (3Y)
1.3%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹7.67
Bear case
Discount -171.0%
Base case
Discount -41.8%
Bull case
Discount -16.2%
Ratio Trends
LASA · last 9 annual periods
ROE
-17.6%
ROCE
-5.1%
Operating Margin
—
Debt / Equity
0.03×
PE
—
EV / EBITDA
26.0×
Historical Financials
LASA · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 NSE_XBRL | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹202 Cr | ₹137 Cr | ₹130 Cr | ₹104 Cr | ₹142 Cr | -8.4% |
| EBITDA | — | ₹8.4 Cr | ₹-24.7 Cr | ₹-6.5 Cr | ₹-4.4 Cr | — |
| EBIT | ₹31.5 Cr | ₹-6.2 Cr | ₹-38.1 Cr | ₹-17.2 Cr | — | — |
| PAT | ₹22.8 Cr | ₹-5.3 Cr | ₹-38.6 Cr | ₹-21.7 Cr | ₹-14.8 Cr | — |
| EPS (diluted) | ₹5.60 | ₹-1.32 | ₹-7.71 | ₹-4.34 | — | — |
| CFO | ₹41.3 Cr | ₹9.2 Cr | ₹-17.3 Cr | ₹1.8 Cr | ₹-2.8 Cr | — |
| CapEx | — | — | — | ₹-1.7 Cr | — | — |
| FCF | — | — | — | ₹0.2 Cr | — | +0.0% |
| Total Assets | — | ₹209 Cr | ₹164 Cr | ₹151 Cr | ₹102 Cr | -16.5% |
| Total Debt | — | ₹20.2 Cr | ₹21.8 Cr | ₹22.1 Cr | ₹2.1 Cr | -43.0% |
| Shareholders' Equity | — | ₹158 Cr | ₹118 Cr | ₹96.7 Cr | ₹83.7 Cr | -14.7% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
LASA vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
MANGALAM MANGALAM | — | — | Pending | -43.1% | — |
BIOFILCHEM BIOFILCHEM | — | — | Pending | 3.0% | — |
VIVIMEDLAB VIVIMEDLAB | — | — | Pending | 90.9% | — |
VAISHALI VAISHALI | — | — | Pending | 1.3% | — |
PAR PAR | — | — | Pending | 13.5% | — |
Click a ticker to view its fair-value analysis.
Dividend History
2 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹0.50/sh
Last payout
2022-09-16
₹0.25
Peak payout
₹0.25
Trailing yield
—
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of LASA →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for LASA →
Compare
Head-to-head with peers
Compare LASA side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse LASANow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.